⌘K

Login Start Free

Home/Filings/4/0001209191-22-059113

4//SEC Filing

Ball Jack 4

Accession 0001209191-22-059113

CIK 0001831915other

View on SEC.gov Company Profile

Filed

Nov 29, 7:00 PM ET

Accepted

Nov 30, 7:39 PM ET

Size

10.7 KB

Accession

0001209191-22-059113

Insider Transaction Report

Form 4

Period: 2022-11-29

Cytek Biosciences, Inc.CTKB

Director

Transactions

Exercise/Conversion
Common Stock
2022-11-29$0.92/sh+13,333$12,266→ 26,999 total
Exercise/Conversion
Stock Option (Right to Buy)
2022-11-29−10,666→ 0 total
Exercise: $0.40From: 2020-10-12Exp: 2028-10-12→ Common Stock (10,666 underlying)
Exercise/Conversion
Common Stock
2022-11-29$0.40/sh+10,666$4,266→ 13,666 total
Exercise/Conversion
Stock Option (Right to Buy)
2022-11-29−13,333→ 0 total
Exercise: $0.92Exp: 2030-07-24→ Common Stock (13,333 underlying)

Footnotes (1)

[F1]The shares subject to the option vest as follows: 1/12th of the shares subject to the option shall vest monthly over one year from July 24, 2020.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Cytek Biosciences, Inc.

CIK 0001831915

Entity typeother

Related Parties

1

filerCIK 0001873083

Filing Metadata

Form type: 4
Filed: Nov 29, 7:00 PM ET
Accepted: Nov 30, 7:39 PM ET
Size: 10.7 KB

View on SEC.gov